Bates M D, Newbold C I, Jarra W, Brown K N
Division of Parasitology, National Institute for Medical Research, London, UK.
Parasite Immunol. 1988 Jan;10(1):1-15. doi: 10.1111/j.1365-3024.1988.tb00199.x.
The protective effect of affinity purified antigen has been investigated in an experimental model for malaria which shows a well marked recrudescence of parasitaemia, a feature of the disease in man. A monoclonal antibody (MoAb) recognizing an epitope common to two genetically distinct cloned lines of Plasmodium chabaudi (AS and CB), was used to purify a Mr250,000 polymorphic schizont antigen (PSA) from these parasites. The purified preparations were then examined for the presence of specific and cross-reactive epitopes by immunoprecipitation with a panel of MoAb raised against P. chabaudi AS. When tested previously on smears of parasitized blood by immunofluorescence, or against lysates of parasitized erythrocytes by immunoprecipitation, most of these MoAb had been found to be AS specific. When either AS or CB affinity purified Mr250,000 PSA was used as the target, these same MoAb immunoprecipitated both antigens, and in some cases, a number of associated polypeptides (AP) which copurify with the Mr250,000 PSA. Subsequently, mice were immunized with either the purified AS or CB antigens in Freund's complete adjuvant (FCA). Prechallenge sera were compared by indirect immunofluorescence and immunoprecipitation. Sera from mice immunized with AS antigen reacted strongly with AS and cross-reacted with CB parasite preparations. Pre-challenge serum from CB antigen immunized mice reacted well with CB, but only faintly with AS preparations. In mice immunized with the AS antigen and then challenged with either AS or CB parasites, the initial parasitaemias were delayed in appearance and the height of the peak parasitaemia reduced, an effect which was most pronounced after challenge with homologous parasites. Only homologous challenge of the mice immunized with CB antigen produced statistically significant modification of the initial parasitaemia. In the immunized mice challenged with homologous parasites, the delayed appearance and slightly reduced peak of the primary parasitaemia was associated with delayed resolution of the patent parasitaemia and significant enhancement of the recrudescence.
在疟疾实验模型中研究了亲和纯化抗原的保护作用,该模型显示出明显的寄生虫血症复发,这是人类疟疾的一个特征。一种识别两种遗传上不同的查巴迪疟原虫克隆系(AS和CB)共有的表位的单克隆抗体(MoAb),用于从这些寄生虫中纯化一种分子量为250,000的多态性裂殖体抗原(PSA)。然后用一组针对查巴迪疟原虫AS产生的MoAb通过免疫沉淀法检测纯化制剂中特异性和交叉反应性表位的存在。以前通过免疫荧光在感染寄生虫的血液涂片上进行检测,或通过免疫沉淀法针对感染红细胞的裂解物进行检测时,发现这些MoAb大多数是AS特异性的。当使用AS或CB亲和纯化的分子量为250,000的PSA作为靶标时,这些相同的MoAb能免疫沉淀两种抗原,并且在某些情况下,还能沉淀一些与分子量为250,000的PSA共纯化的相关多肽(AP)。随后,用弗氏完全佐剂(FCA)中的纯化AS或CB抗原免疫小鼠。通过间接免疫荧光和免疫沉淀法比较攻击前血清。用AS抗原免疫的小鼠血清与AS强烈反应并与CB寄生虫制剂交叉反应。用CB抗原免疫的小鼠攻击前血清与CB反应良好,但与AS制剂反应微弱。在用AS抗原免疫然后用AS或CB寄生虫攻击的小鼠中,初始寄生虫血症的出现延迟,寄生虫血症峰值高度降低,在用同源寄生虫攻击后这种效果最为明显。仅用CB抗原免疫的小鼠进行同源攻击才对初始寄生虫血症产生统计学上显著的改变。在用同源寄生虫攻击的免疫小鼠中,原发性寄生虫血症延迟出现和峰值略有降低与显性寄生虫血症的延迟消退和复发的显著增强有关。